Brightstone Venture Capital
Brightstone Venture Capital manages a $100 million venture fund focused on early-growth stage investment opportunities. The firm leverages the deep operating experience and successful investment background of its partners, primarily focusing on investing in technology and life sciences sectors. Brightstone aims to help extraordinary entrepreneurs build exceptional companies by providing strategic guidance and capital to drive growth and innovation.
Brightstone Venture Capital
Portfolio
The Miromatrix Medical technology has the potential to enable the creation of fully biological replacement organs for the human body.
#Life Sciences
Intact Therapeutics is a next generation localized drug delivery technology platform.
#Life Sciences
Aria CV is developing a pulmonary assist device to improve the lives of patients living with Pulmonary Arterial Hypertension.
#Life Sciences
Eternal is a avatar based social network giving groups of users a canvas for their friendships to live on and grow.
#Technology
LifeLens created a simple, commercially viable platform to monitor a wide range of human physiologic and cardiology measurements in real time.
#Life Sciences
Vori has developed an innovative healthcare platform that includes full service physical medicine and rehabilitation care, virtual physical therapy, prescriptions, imaging & lab ordering, health coaching, nutritional guidance, community support and premium instructional content.
#Life Sciences